Skip to main content
. Author manuscript; available in PMC: 2023 Sep 1.
Published in final edited form as: Hepatology. 2022 Mar 31;76(3):689–699. doi: 10.1002/hep.32448

Tables 3A-C.

Reclassification of Liver Transplant Candidates Between MELDNa and MELDNa-KT in the Validation Set.

3A. Overall (n)
Percentile of Risk and MELDNa-KT Category
Percentile of Risk with MELDNa (%) and MELDNa Category <20 20–39 40–59 60–79 >80
6–26 27–31 31–34 35–38 >38
<20 6–26 16763 253 0 0 0
20–39 27–31 173 1345 246 0 0
40–59 31–34 0 60 238 104 0
60–79 35–38 0 0 49 80 89
>80 >38 0 0 0 11 101
3B. Cases (n)
Percentile of Risk and MELDNa-KT Category
<20 20–39 40–59 60–79 >80
Percentile of Risk with MELDNa (%) 6–26 27–31 31–34 35–38 >38
<20 6–26 831 44 0 0 0
20–39 27–31 22 276 69 0 0
40–59 31–34 0 12 79 50 0
60–79 35–38 0 0 15 27 52
>80 >38 0 0 0 5 61
3C. Controls (n)
Percentile of Risk and MELDNa-KT Category
<20 20–39 40–59 60–79 >80
Percentile of Risk with MELDNa (%) 6–26 27–31 31–34 35–38 >38
<20 6–26 15942 209 0 0 0
20–39 27–31 151 1069 177 0 0
40–59 31–34 0 48 159 54 0
60–79 35–38 0 0 34 53 37
>80 >38 0 0 0 6 40
*

Green demarcation indicates areas of up-scoring (MELDNa-KT category higher than MELDNa); Red demarcation indicates areas of down-scoring